Impact Factor
4.57
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
13.18
1,552 total citations
h5-index
55
h5 depth signal
Cited share
92.7%
115 of 124
Total citations
1,552
Citation footprint
Metric signal
22.52
External metric anchor
Self-citation
1.7%
27 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
478
United States
58
Spain
16
India
13
Italy
13
Citing Fields of Research
Immunology
152
Cancer & Development
90
Cancer, Autophagy & Apoptosis
76
Oncology
58
Noncoding RNA
56
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
599
Articles tracked across the journal lifetime
Indexed publication set
124
115 cited publications
Last 12 months
274
22.8 publications/month
Open access share
100.0%
274 OA publications in the last year
Leading citing country
China
478 citing publications
Leading citing field
Immunology
152 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v5, 2024-
v1, Dec. 2020-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Cancer, Autophagy & Apoptosis
Cancer & Development
Noncoding RNA
Oncology
Genetics & Genomics
Broad Categories
Medicine
Pathology
Cancer, Autophagy & Apoptosis
Immunology
Virology
Noncoding RNA
Cancer & Development
Nucleic Acids Chemistry
MeSH Descriptors
Biomedical Engineering
Biotechnology
Molecular Medicine
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1186/s43556-026-00598-y
Open DOI
Synthetic Notch CD123 and CLL1 chimeric antigen receptor T-cells (CAR-T) target acute myeloid leukemia and reduce off-tumor effects associated with CLL1 CAR-T cells
Chimeric antigen receptor T-cell (CAR-T) therapy targeting the C-type lectin-like molecule-1 (CLL1) antigen has emerged as a promising therapeutic approach for acute myeloid leukemia (AML). However, its clinical translation is hindered b...
02
DOI 10.1186/s43556-026-00606-1
Open DOI
Curcumin alleviates metabolic dysfunction-associated steatotic liver disease via gut microbiota-dependent epigenetic alterations
Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly prevalent, yet effective therapies remain limited. Curcumin (Cur), a polyphenol with well-documented metabolic benefits, shows therapeutic promise in MASLD,...
03
DOI 10.1186/s43556-026-00618-x
Open DOI
Docosahexaenoic acid remodels lipid composition of lipid rafts and mitochondrial function in ApoE4/4 mouse brain: a multi-omic investigation
Alzheimer’s disease (AD) is an irreversible neurodegenerative disorder lacking curative therapies, with ApoE4 as the strongest genetic risk factor driving lipid dyshomeostasis and neuronal damage in the central nervous system. Lipid raft...
04
DOI 10.1186/s43556-026-00623-0
Open DOI
Colitis-associated colorectal carcinogenesis: molecular mechanisms and therapeutic potential
Chronic colitis is a major risk factor for colorectal cancer (CRC), particularly for colitis-associated colorectal cancer (CAC), where persistent inflammation drives the transition from mucosal injury to malignant transformation. Accumul...
05
DOI 10.1186/s43556-026-00622-1
Open DOI
Alistipes-derived monomethyl branched-chain fatty acid iso-15:0 suppresses hepatocellular carcinoma progression by inhibiting Gβγ/PI3K/AKT signaling
The role of gut microbiota and their metabolites in the progression of hepatocellular carcinoma (HCC) has garnered increasing attention. Although Alistipes , a genus frequently reported as a beneficial bacterium, has been associated with...
06
DOI 10.1186/s43556-026-00617-y
Open DOI
Epigenetically silencing gluconeogenic enzyme PCK1 by EZH2 promotes renal tubulointerstitial fibrosis
Chronic kidney disease (CKD) is a leading cause of global morbidity. The kidney is a major gluconeogenic organ, and impaired renal gluconeogenesis contributes to CKD, yet the regulatory mechanisms remain poorly understood. Here we show t...
07
DOI 10.1186/s43556-026-00593-3
Open DOI
Mechanotransduction through oxidative stress upregulates circLyst to drive vascular remodeling in hypertensive humans and rodents
Aberrant cyclic stretch serves as a critical driver of vascular remodeling in hypertension, yet the underlying molecular mechanisms remain largely unknown. Here, we studied the role of a novel circRNA, termed circ_2465 (circLyst), in vas...
08
DOI 10.1186/s43556-026-00616-z
Open DOI
The ubiquitin–proteasome system and proteostasis in the cochlea and sensorineural hearing disorders
The ubiquitin–proteasome system (UPS) is the major machinery for intracellular protein degradation, playing an indispensable role in maintaining proteostasis across all tissues. Sensorineural hearing loss affects billions of people world...
09
DOI 10.1186/s43556-026-00626-x
Open DOI
CUE domain-containing 2 promotes diffuse large B-cell lymphoma progression via PP2A-B55β degradation and shapes macrophage-mediated immune responses
CUE domain-containing 2 (CUEDC2) regulates ubiquitin-mediated protein turnover, cell-cycle progression, and inflammatory signaling, but its role in diffuse large B-cell lymphoma (DLBCL) remains unclear. DLBCL is the most common aggressiv...
10
DOI 10.1186/s43556-026-00608-z
Open DOI
Renal stress-associated extracellular vesicle signaling linked to lysosomal cathepsin D and NEK7–NLRP3 neuroinflammation
Systemic exposure to neurotoxins such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects both the central nervous system (CNS) and peripheral organs; however, the contribution of peripheral organ stress to neuroinflammation r...
Bibliographical & Catalog Notes
Articles added online as accepted throughout the year.